Displaying archives for 2014 June:

Woman survives scary lung cancer diagnosis and finds new life’s work

Posted by Samantha Powell on June 22nd, 2014 |

Six months to live. Mary Jo Grand sat in the sterile exam room. The tumors spat out by her undiagnosed lung cancer had lit up the PET scan — dense black splotches throughout her lungs and arms and abdomen and neck and chest. The doctor was talking. Grim, horrible statistics. Treatment. Experimental medicine. Grand hadn’t… Read More

Cancer Doctors Ring Up Big Medicare Bills for Tarnished Drug Procrit

Posted by Samantha Powell on June 19th, 2014 |

Many cancer doctors now use a drug called Procrit sparingly. It was approved in 1989 for anemia and became a popular treatment for that side effect of chemotherapy. But regulators later learned Procrit can speed tumor growth and hasten death in cancer patients. Today, use of this class of drug—best known as EPO, a substance… Read More

OncLive to Host “Giants of Cancer Care” Celebration Event in New York City

Posted by Samantha Powell on June 18th, 2014 |

The 2014 Giants of Cancer Care are here, and tomorrow OncLive will host a special celebration event in New York City to honor the three Big Apple-based members of this year’s class of Giants. The reception, which will feature remarks from OncLive representatives, local Giants and other industry leaders, will be held at the Sheraton… Read More

Purple toes campaign fights back against lung cancer

Posted by Samantha Powell on June 17th, 2014 |

What started out as simple gesture by a man who wanted to lighten his wife’s mood during her battle with cancer has become something of a movement. And it all began with a purple pedicure. Valerie Brosdal, 53, a non-smoker, was diagnosed with stage IV lung cancer back in August. Some days are better than… Read More

Medicare’s Puzzling Refusal to Cover Lung-Cancer Screening

Posted by Samantha Powell on June 17th, 2014 |

If you could save thousands of lives, would you do it? That’s the question Medicare officials are now considering—whether to approve lung-cancer screening for Medicare beneficiaries, which we estimate could save 14,000 lives each year in that group alone. Most patients are discovered with lung cancer at a stage already too late for a cure,… Read More

Richard Heimler Honored as June LUNGevity Hero

Posted by Samantha Powell on June 16th, 2014 |

LUNGevity Foundation announces Richard Heimler, seven-time lung cancer survivor and father of two, as the June LUNGevity Hero for his advocacy and awareness-raising. Since his diagnosis in spring 2004, Richard has jumped into action – fighting the disease for a remarkable ten years while also advocating for more funds for important, lifesaving lung cancer research…. Read More

Helping patients cope with a lung cancer diagnosis

Posted by Samantha Powell on June 16th, 2014 |

Thoracic oncology navigation involves directing patients to resources, providing education about the disease and its treatments, coordinating patient care, providing information on benefits and assisting with insurance authorizations, and bridging the communication gap between patients and the health care team. The role of the thoracic oncology nurse navigator and how it fits into the multidisciplinary… Read More

New study aims to rapidly test lung cancer drugs

Posted by Samantha Powell on June 16th, 2014 |

A bold new way to test cancer drugs started Monday in hundreds of hospitals around the U.S. In a medical version of speed dating, doctors will sort through multiple experimental drugs and match patients to the one most likely to succeed based on each person’s unique tumor gene profile. It’s a first-of-a-kind experiment that brings… Read More

Amgen Joins National Cancer Institute, Other Companies On Lung-MAP Project

Posted by Samantha Powell on June 16th, 2014 |

Amgen announced that it will collaborate with the National Cancer Institute and other public and private sector partners on the Lung Master Protocol (Lung-MAP), a clinical trial program that will use biomarker-driven research and genomic profiling to match squamous cell lung cancer patients to investigational treatments based on their individual cancer profiles. In the U.S.,… Read More

Lung-MAP trial launched, matching patients to treatments based on tumor profiles

Posted by Samantha Powell on June 16th, 2014 |

A phase II/III trial using genomic profiling to match patients with investigational treatments began recruiting patients with advanced squamous cell lung cancer on June 16, 2014. The Lung-MAP (Lung Cancer Master Protocol) trial is a public-private collaboration among the National Cancer Institute (NCI), SWOG Cancer Research, Friends of Cancer Research, the Foundation for the National… Read More